D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion

Blood

Volumn 118, Issue 23, 2011, Pages 6220-6229

  Lee, Kit Ming ^a   McKimmie, Clive S ^a   Gilchrist, Derek S ^a   Pallas, Kenneth J ^a   Nibbs, Robert J ^a   Garside, Paul ^a   McDonald, Victoria ^b   Jenkins, Christopher ^c   Ransohoff, Richard ^d   Liu, LiPing ^d   Milling, Simon ^a   Cerovic, Vuk ^a   Graham, Gerard J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR7; D6 CHEMOKINE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1 INHIBITOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL MOTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUID FLOW; HOMEOSTASIS; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; LYMPH NODE; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC CONGESTION; LYMPHATIC DRAINAGE; LYMPHATIC PARAMETERS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 83055179249     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-03-344044     Document Type: Article

References (47)

1. Witte MH, Jones K, Wilting J, et al. Structure function relationships in the lymphatic system and implications for cancer biology. Cancer Metastasis Rev. 2006;25(2):159-184. (Pubitemid 43886395)
2. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol. 2004;22:891-928. (Pubitemid 38680444)
3. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today. 1999;20(6):254-257. (Pubitemid 29258161)
4. Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol. 2008;8(5):362-371. (Pubitemid 351595218)
5. Graham GJ. D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes. Eur J Immunol. 2009;39(2):342-351.
6. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol. 2006;6(12):907-918. (Pubitemid 44851733)
7. Boidajipour B, Mahabaleshwar H, Kardash E, et al. Control of chemokine-guided cell migration by ligand sequestration. Cell. 2008;132(3):463-473. (Pubitemid 351191997)
8. Fra AM, Locati M, Otero K, et al. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J Immunol. 2003;170(5):2279-2282. (Pubitemid 36245612)
9. Weber M, Blair E, Simpson CV, et al. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell. 2004;15(5):2492-2508. (Pubitemid 38580663)
10. Nibbs RJ, Wylie SM, Yang J, Landau NR, Graham GJ. Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem. 1997;272(51):32078-32083. (Pubitemid 28011878)
11. Bonecchi R, Locati M, Galliera E, et al. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage- derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol. 2004;172(8):4972-4976. (Pubitemid 38456423)
12. Nibbs RJ, Wylie SM, Pragnell IB, Graham GJ. Cloning and characterization of a novel murine beta chemokine receptor, D6: comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5. J Biol Chem. 1997;272(19):12495-12504. (Pubitemid 27203340)
13. Di Liberto D, Locati M, Caccamo N, et al. Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J Exp Med. 2008;205(9):2075-2084.
14. Jamieson T, Cook DN, Nibbs RJ, et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol. 2005;6(4):403-411. (Pubitemid 41716781)
15. Martinez de la Torre Y, Buracchi C, Borroni EM, et al. Protection against inflammation- and autoantibody- caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci U S A. 2007;104(7):2319-2324. (Pubitemid 46391395)
16. Martinez de la Torre Y, Locati M, Buracchi C, et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol. 2005;35(5):1342-1346. (Pubitemid 40691415)
17. Vetrano S, Borroni EM, Sarukhan A, et al. The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6. Gut 2010;59(2):197-206.
18. Whitehead GS, Wang T, DeGraff LM, et al. The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am J Respir Crit Care Med. 2007;175(3):243-249. (Pubitemid 46203127)
19. Nibbs RJ, Kriehuber E, Ponath PD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol. 2001;158(3):867-877. (Pubitemid 32221780)
20. Graham GJ, McKimmie CS. Chemokine scavenging by D6: a movable feast? Trends Immunol. 2006;27(8):381-386. (Pubitemid 44038664)
21. McKimmie CS, Fraser AR, Hansell C, et al. Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol. 2008;181(5):3353-3363.
22. Nibbs RJ, Gilchrist DS, King V, et al. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest. 2007;117(7):1884-1892. (Pubitemid 47036322)
23. Milling SW, Jenkins C, MacPherson G. Collection of lymph-borne dendritic cells in the rat. Nat Protoc. 2006;1(5):2263-2270.
24. Edwards JC, Sedgwick AD, Willoughby DA. The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J Pathol. 1981;134(2):147-156. (Pubitemid 11065839)
25. Nibbs RJ, Yang J, Landau NR, Mao JH, Graham GJ. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity. J Biol Chem. 1999;274(25):17478-17483.
26. Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999;99(1):23-33. (Pubitemid 29468627)
27. Xu Y, Zhan Y, Lew AM, Naik SH, Kershaw MH. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol. 2007;179(11):7577-7584.
28. McKimmie CS, Moore M, Fraser AR, et al. A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. Blood. 2009;113(18):4224-4231.
29. Hernandez-Hoyos G, Joseph S, Miller NG, Butcher GW. The lymphopenia mutation of the BB rat causes inappropriate apoptosis of mature thymocytes. Eur J Immunol. 1999;29(6):1832-1841. (Pubitemid 29265538)
30. Itano AA, McSorley SJ, Reinhardt RL, et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity. 2003;19(1):47-57. (Pubitemid 36859900)
31. MartIn-Fontecha A, Sebastiani S, Hopken UE, et al. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med. 2003;198(4):615-621.
32. Milling S, Yrlid U, Cerovic V, MacPherson G. Subsets of migrating intestinal dendritic cells. Immunol Rev; 2010;234(1):259-267.
33. Liu L, Graham GJ, Damodaran A, et al. Cutting edge: the silent chemokine receptor d6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis. J Immunol. 2006;177(1):17-21. (Pubitemid 43939108)
34. Nagao K, Ginhoux F, Leitner WW, et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci U S A. 2009;106(9):3312-3317.
35. Britschgi MR, Favre S, Luther SA. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19. Eur J Immunol 2010;40(5):1266-1271.
36. Bedoui S, Whitney PG, Waithman J, et al. Cross-presentation of viral and self antigens by skinderived CD103+ dendritic cells. Nat Immunol. 2009;10(5):488-495.
37. Sironi M, Conti A, Bernasconi S, et al. Generation and characterization of a mouse lymphatic endothelial cell line. Cell Tissue Res. 2006;325(1):91-100. (Pubitemid 44124301)
38. Johnson LA, Clasper S, Holt AP, Lalor PF, Baban D, Jackson DG. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med. 2006;203(12):2763-2777. (Pubitemid 44833351)
39. Mirzadegan T, Diehl F, Ebi B, et al. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J Biol Chem. 2000;275(33):25562-25571.
40. Thomas-Ecker S, Lindecke A, Hatzmann W, Kaltschmidt C, Zanker KS, Dittmar T. Alteration in the gene expression pattern of primary monocytes after adhesion to endothelial cells. Proc Natl Acad Sci U S A. 2007;104(13):5539-5544. (Pubitemid 47175716)
41. Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W. Tumor necrosis factor alpha (TNFalpha)- induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med. 1993;177(5):1277-1286. (Pubitemid 23117119)
42. Viemann D, Goebeler M, Schmid S, et al. TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukoc Biol. 2006;80(1):174-185. (Pubitemid 44835538)
43. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med. 2000;192(10):1425-1440.
44. Palframan RT, Jung S, Cheng G, et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med. 2001;194(9):1361-1373. (Pubitemid 33055053)
45. Bromley SK, Thomas SY, Luster AD. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol. 2005;6(9):895-901. (Pubitemid 43090444)
46. Pflicke H, Sixt M. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J Exp Med. 2009;206(13):2925-2235.
47. Mancardi S, Vecile E, Dusetti N, et al. Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology. 2003;108(4):523-530. (Pubitemid 36469690)